Nazione: Irlanda
Lingua: inglese
Fonte: HPRA (Health Products Regulatory Authority)
albendazole
Pfizer Healthcare Ireland
QP52AC11
100 Mg/Ml
Oral Suspension
Bovine Ovine
Endoparasiticide
Authorised
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Valbazen 100 mg/ml Total Spectrum Wormer 2 QUALITATIVE AND QUANTITATIVE COMPOSITION For a full list of excipients see section 6.1. 3 PHARMACEUTICAL FORM Oral suspension. A pale blue aqueous suspension. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Cattle and sheep 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For the control of benzimidazole susceptible mature and developing immature forms of the following internal parasites of cattle and sheep. Cattle Gastro-intestinal roundworms: _Ostertagia, Chabertia, Cooperia, Trichostrongylus, Nematodirus, Haemonchus,_ _Bunostomum, Oesophagostomum and Strongyloides spp_. Lungworms: _Dictyocaulus viviparus_ Sheep Gastro-intestinal roundworms: _Ostertagia, Haemonchus, Trichostrongylus, Nematodirus (including N battus),_ _Chabertia and Oesophagostomum spp_. Lungworms : _Dictyocaulus filaria_ For the control of tapeworms, _Moniezia spp_, in cattle and sheep. For the control of adult liver flukes, _Fasciola hepatica_, in cattle and sheep. In cattle it is usually effective against inhibited larvae of _Cooperia _and _Ostertagia_. In sheep it is usually effective against inhibited larvae of benzimidazole susceptible _Ostertagia_. The product is ovicidal. Each ml contains: Active substance Albendazole 100 mg Excipients Potassium sorbate 1.5 mg Benzoic acid 1.8 mg Acid Brilliant Green (E142) 0.026 mg IRISH MEDICINES BOARD ________________________________________________________________________________________________________________________ _Date Printed 29/11/2010_ _CRN 7006079_ _page number: 1_ 4.3 CONTRAINDICATIONS Do not use in sheep producing milk for human consumption. Do not dose ewes at the ‘fluke and worm’ dose rate (7.5 mg/kg) during tupping and for 1 month after removing rams. Do not use in animals with Leggi il documento completo